OTC Markets EXMKT - Delayed Quote USD

AmeriCann, Inc. (ACAN)

0.0001
0.0000
(0.00%)
At close: May 20 at 10:00:43 AM EDT
Loading Chart for ACAN
  • Previous Close 0.0001
  • Open 0.0001
  • Bid 0.0156 x --
  • Ask 0.0225 x --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0797
  • Volume 500
  • Avg. Volume 34,964
  • Market Cap (intraday) 2,439
  • Beta (5Y Monthly) 1.34
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0900
  • Earnings Date Aug 11, 2025 - Aug 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company's flagship project is the Massachusetts Cannabis Center that is developed on a 52.6 -acre parcel of undeveloped land located in Freetown, Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is headquartered in Denver, Colorado.

americann.co

3

Full Time Employees

September 30

Fiscal Year Ends

Recent News: ACAN

View More

Performance Overview: ACAN

Trailing total returns as of 5/20/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ACAN
99.75%
S&P 500 (^GSPC)
1.00%

1-Year Return

ACAN
99.84%
S&P 500 (^GSPC)
11.91%

3-Year Return

ACAN
99.97%
S&P 500 (^GSPC)
52.27%

5-Year Return

ACAN
99.98%
S&P 500 (^GSPC)
99.91%

Compare To: ACAN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACAN

View More

Valuation Measures

Annual
As of 5/20/2025
  • Market Cap

    2.44k

  • Enterprise Value

    6.66M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.00

  • Price/Book (mrq)

    0.00

  • Enterprise Value/Revenue

    8.33

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -297.94%

  • Return on Assets (ttm)

    -5.74%

  • Return on Equity (ttm)

    -54.80%

  • Revenue (ttm)

    799.18k

  • Net Income Avi to Common (ttm)

    -2.38M

  • Diluted EPS (ttm)

    -0.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    131.16k

  • Total Debt/Equity (mrq)

    215.22%

  • Levered Free Cash Flow (ttm)

    -371.98k

Research Analysis: ACAN

View More

Company Insights: ACAN

Research Reports: ACAN

View More

People Also Watch